Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Treatment strategies for polycythemia vera: Observations in a Dutch "real-world" cohort study.

van de Ree-Pellikaan C, de Kreuk A, Schaar CG, Beeker A, Dompeling EC, Gerrits CJH, van Houten AA, Schipperus MR, Strobbe L, Posthuma EFM, Klauke K, Westerweel PE.

Eur J Haematol. 2019 Nov;103(5):453-459. doi: 10.1111/ejh.13291. Epub 2019 Sep 5.

PMID:
31298768
2.

Guideline use among different healthcare professionals in diagnosing attention deficit hyperactivity disorder in Dutch children; who cares?

Levelink B, Walraven L, Dompeling E, Feron FJM, van Zeben-van der Aa DMCB.

BMC Psychol. 2019 Jul 3;7(1):43. doi: 10.1186/s40359-019-0304-1.

3.

Exhaled Breath Condensate in Childhood Asthma: A Review and Current Perspective.

Bannier MAGE, Rosias PPR, Jöbsis Q, Dompeling E.

Front Pediatr. 2019 Apr 25;7:150. doi: 10.3389/fped.2019.00150. eCollection 2019. Review.

4.

Publisher Correction: Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function.

van Horck M, Winkens B, Wesseling G, van Vliet D, van de Kant K, Vaassen S, de Winter-de Groot K, de Vreede I, Jöbsis Q, Dompeling E.

Sci Rep. 2018 Dec 13;8(1):17946. doi: 10.1038/s41598-018-36407-y.

5.

Feasibility and diagnostic accuracy of an electronic nose in children with asthma and cystic fibrosis.

Bannier MAGE, van de Kant KDG, Jöbsis Q, Dompeling E.

J Breath Res. 2019 May 8;13(3):036009. doi: 10.1088/1752-7163/aae158.

PMID:
30213921
6.

Risk factors for lung disease progression in children with cystic fibrosis.

van Horck M, van de Kant K, Winkens B, Wesseling G, Gulmans V, Hendriks H, van der Grinten C, Jöbsis Q, Dompeling E.

Eur Respir J. 2018 Jun 7;51(6). pii: 1702509. doi: 10.1183/13993003.02509-2017. Print 2018 Jun.

PMID:
29773689
7.

Children With ADHD Symptoms: Who Can Do Without Specialized Mental Health Care?

Levelink B, Feron FJM, Dompeling E, van Zeben-van de Aa DMCB.

J Atten Disord. 2018 Feb 1:1087054718756194. doi: 10.1177/1087054718756194. [Epub ahead of print]

PMID:
29471702
8.

Recruiting families for an intervention study to prevent second-hand smoke exposure in children.

Hutchinson SG, van Schayck CP, Muris JWM, Feron FJM, Dompeling E.

BMC Pediatr. 2018 Jan 31;18(1):19. doi: 10.1186/s12887-018-0983-4.

9.

Motivational interviewing and urine cotinine feedback to stop passive smoke exposure in children predisposed to asthma: a randomised controlled trial.

Hutchinson SG, van Breukelen G, van Schayck CP, Essers B, Hammond SK, Muris JWM, Feron FJM, Dompeling E.

Sci Rep. 2017 Nov 13;7(1):15473. doi: 10.1038/s41598-017-15158-2.

10.

Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function.

van Horck M, Winkens B, Wesseling G, van Vliet D, van de Kant K, Vaassen S, de Winter-de Groot K, de Vreede I, Jöbsis Q, Dompeling E.

Sci Rep. 2017 Sep 27;7(1):12350. doi: 10.1038/s41598-017-10945-3. Erratum in: Sci Rep. 2018 Dec 13;8(1):17946.

11.

Correction: A Multifactorial Weight Reduction Programme for Children with Overweight and Asthma: A Randomized Controlled Trial.

Willeboordse M, van de Kant KDG, Tan FES, Mulkens S, Schellings J, Crijns Y, van der Ploeg L, van Schayck CP, Dompeling E.

PLoS One. 2017 Jul 6;12(7):e0181130. doi: 10.1371/journal.pone.0181130. eCollection 2017.

12.

Factors associated with changes in health-related quality of life in children with cystic fibrosis during 1-year follow-up.

van Horck M, Winkens B, Wesseling G, de Winter-de Groot K, de Vreede I, Jöbsis Q, Dompeling E.

Eur J Pediatr. 2017 Aug;176(8):1047-1054. doi: 10.1007/s00431-017-2928-6. Epub 2017 Jun 9.

13.

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.

Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, Boots AW, Bos LD, Brinkman P, Bucca C, Carpagnano GE, Corradi M, Cristescu S, de Jongste JC, Dinh-Xuan AT, Dompeling E, Fens N, Fowler S, Hohlfeld JM, Holz O, Jöbsis Q, Van De Kant K, Knobel HH, Kostikas K, Lehtimäki L, Lundberg J, Montuschi P, Van Muylem A, Pennazza G, Reinhold P, Ricciardolo FLM, Rosias P, Santonico M, van der Schee MP, van Schooten FJ, Spanevello A, Tonia T, Vink TJ.

Eur Respir J. 2017 Apr 26;49(4). pii: 1600965. doi: 10.1183/13993003.00965-2016. Print 2017 Apr.

14.

Predictive value of serum sST2 in preschool wheezers for development of asthma with high FeNO.

Ketelaar ME, van de Kant KD, Dijk FN, Klaassen EM, Grotenboer NS, Nawijn MC, Dompeling E, Koppelman GH.

Allergy. 2017 Nov;72(11):1811-1815. doi: 10.1111/all.13193. Epub 2017 May 23.

PMID:
28440062
15.

Introduction of a new paediatric asthma guideline: Effects on asthma control levels.

Hammer SC, Sonneveld LJH, van de Kant KDG, Hendriks HJ, Heynens JW, Droog R, Dompeling E, Jöbsis Q.

Pediatr Allergy Immunol. 2017 May;28(3):266-272. doi: 10.1111/pai.12697. Epub 2017 Mar 28.

PMID:
28107572
16.

Can exhaled volatile organic compounds predict asthma exacerbations in children?

van Vliet D, Smolinska A, Jöbsis Q, Rosias P, Muris J, Dallinga J, Dompeling E, van Schooten FJ.

J Breath Res. 2017 Mar 1;11(1):016016. doi: 10.1088/1752-7163/aa5a8b.

PMID:
28102830
17.

Associations between asthma, overweight and physical activity in children: a cross-sectional study.

Willeboordse M, van de Kant KD, van der Velden CA, van Schayck CP, Dompeling E.

BMC Public Health. 2016 Sep 1;16:919. doi: 10.1186/s12889-016-3600-1.

18.

A Multifactorial Weight Reduction Programme for Children with Overweight and Asthma: A Randomized Controlled Trial.

Willeboordse M, van de Kant KDG, Tan FE, Mulkens S, Schellings J, Crijns Y, Ploeg Lv, van Schayck CP, Dompeling E.

PLoS One. 2016 Jun 13;11(6):e0157158. doi: 10.1371/journal.pone.0157158. eCollection 2016. Erratum in: PLoS One. 2017 Jul 6;12 (7):e0181130.

19.

Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.

van Horck M, Alonso A, Wesseling G, de Winter-de Groot K, van Aalderen W, Hendriks H, Winkens B, Rijkers G, Jöbsis Q, Dompeling E.

PLoS One. 2016 Apr 6;11(4):e0152156. doi: 10.1371/journal.pone.0152156. eCollection 2016.

20.

Association between exhaled inflammatory markers and asthma control in children.

Van Vliet D, Smolinska A, Jöbsis Q, Rosias PP, Muris JW, Dallinga JW, van Schooten FJ, Dompeling E.

J Breath Res. 2016 Feb 19;10(1):016014. doi: 10.1088/1752-7155/10/1/016014.

PMID:
26893372
21.

Erratum to: Intact IFN-γR1 Expression and Function Distinguishes Langerhans Cell Histiocytosis From Mendelian Susceptibility to Mycobacterial Disease.

Quispel WT, Stegehuis-Kamp JA, Santos SJ, van Wengen A, Dompeling E, Egeler RM, van de Vosse E, van Halteren AG.

J Clin Immunol. 2016 Feb;36(2):171-2. doi: 10.1007/s10875-016-0235-z. No abstract available.

PMID:
26783113
22.

Evidence for a Cystic Fibrosis Enteropathy.

Adriaanse MP, van der Sande LJ, van den Neucker AM, Menheere PP, Dompeling E, Buurman WA, Vreugdenhil AC.

PLoS One. 2015 Oct 20;10(10):e0138062. doi: 10.1371/journal.pone.0138062. eCollection 2015.

23.

LucKi Birth Cohort Study: rationale and design.

de Korte-de Boer D, Mommers M, Creemers HM, Dompeling E, Feron FJ, Gielkens-Sijstermans CM, Jaminon M, Mujakovic S, van Schayck OC, Thijs C, Jansen M.

BMC Public Health. 2015 Sep 21;15:934. doi: 10.1186/s12889-015-2255-7.

24.

Prediction of asthma exacerbations in children by innovative exhaled inflammatory markers: results of a longitudinal study.

van Vliet D, Alonso A, Rijkers G, Heynens J, Rosias P, Muris J, Jöbsis Q, Dompeling E.

PLoS One. 2015 Mar 23;10(3):e0119434. doi: 10.1371/journal.pone.0119434. eCollection 2015.

25.

An ADAM33 polymorphism associates with progression of preschool wheeze into childhood asthma: a prospective case-control study with replication in a birth cohort study.

Klaassen EM, Penders J, Jöbsis Q, van de Kant KD, Thijs C, Mommers M, van Schayck CP, van Eys G, Koppelman GH, Dompeling E.

PLoS One. 2015 Mar 13;10(3):e0119349. doi: 10.1371/journal.pone.0119349. eCollection 2015.

26.

Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening.

Vernooij-van Langen A, Dompeling E, Yntema JB, Arets B, Tiddens H, Loeber G, Dankert-Roelse J.

Eur J Pediatr. 2015 Aug;174(8):1025-34. doi: 10.1007/s00431-015-2501-0. Epub 2015 Feb 13.

PMID:
25678232
27.

Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age.

Klaassen EM, van de Kant KD, Jöbsis Q, van Schayck OC, Smolinska A, Dallinga JW, van Schooten FJ, den Hartog GJ, de Jongste JC, Rijkers GT, Dompeling E.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):201-7. doi: 10.1164/rccm.201408-1537OC.

PMID:
25474185
28.

Biomarkers to predict asthma in wheezing preschool children.

Bannier MA, van de Kant KD, Jöbsis Q, Dompeling E.

Clin Exp Allergy. 2015 Jun;45(6):1040-50. doi: 10.1111/cea.12460. Review.

PMID:
25409553
29.

Parental knowledge reduces long term anxiety induced by false-positive test results after newborn screening for cystic fibrosis.

Vernooij-van Langen AM, van der Pal SM, Reijntjens AJ, Loeber JG, Dompeling E, Dankert-Roelse JE.

Mol Genet Metab Rep. 2014 Aug 13;1:334-344. eCollection 2014.

30.

Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms.

Vernooij-van Langen AM, Gerzon FL, Loeber JG, Dompeling E, Dankert-Roelse JE.

Mol Genet Metab. 2014 Sep-Oct;113(1-2):100-4. doi: 10.1016/j.ymgme.2014.07.012. Epub 2014 Jul 16.

PMID:
25077434
31.

CD14/Toll-like receptors interact with bacteria and regulatory T-cells in the development of childhood asthma.

Klaassen EM, van de Kant KD, Soeteman M, Damoiseaux J, van Eys G, Stobberingh EE, Stelma FF, Quaak M, van Schayck OC, Jöbsis Q, Dompeling E.

Eur Respir J. 2014 Sep;44(3):799-802. doi: 10.1183/09031936.00020314. Epub 2014 Jul 17. No abstract available.

32.

Electronic monitoring of symptoms and lung function to assess asthma control in children.

van Vliet D, van Horck M, van de Kant K, Vaassen S, Gulikers S, Winkens B, Rosias P, Heynens J, Muris J, Essers B, Jöbsis Q, Dompeling E.

Ann Allergy Asthma Immunol. 2014 Sep;113(3):257-262.e1. doi: 10.1016/j.anai.2014.05.015. Epub 2014 Jun 18.

PMID:
24950912
33.

Addressing passive smoking in children.

Hutchinson SG, Kuijlaars JS, Mesters I, Muris JW, van Schayck CP, Dompeling E, Feron FJ.

PLoS One. 2014 May 8;9(5):e93220. doi: 10.1371/journal.pone.0093220. eCollection 2014.

34.

Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.

Smolinska A, Klaassen EM, Dallinga JW, van de Kant KD, Jobsis Q, Moonen EJ, van Schayck OC, Dompeling E, van Schooten FJ.

PLoS One. 2014 Apr 21;9(4):e95668. doi: 10.1371/journal.pone.0095668. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105447.

35.

Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma.

Klaassen EM, van de Kant KD, Jöbsis Q, Penders J, van Schooten FJ, Quaak M, den Hartog GJ, Koppelman GH, van Schayck CP, van Eys G, Dompeling E.

Pediatr Allergy Immunol. 2014 Mar;25(2):166-72. doi: 10.1111/pai.12187. Epub 2014 Jan 6.

PMID:
24393359
36.

Intact IFN-γR1 expression and function distinguishes Langerhans cell histiocytosis from mendelian susceptibility to mycobacterial disease.

Quispel WT, Stegehuis-Kamp JA, Santos SJ, van Wengen A, Dompeling E, Egeler RM, van de Vosse E, van Halteren AG.

J Clin Immunol. 2014 Jan;34(1):84-93. doi: 10.1007/s10875-013-9959-1. Epub 2013 Nov 20. Review. Erratum in: J Clin Immunol. 2014 Jul;34(5):600. J Clin Immunol. 2016 Feb;36(2):171-2.

PMID:
24254535
37.

Sex differences in the relationship between asthma and overweight in Dutch children: a survey study.

Willeboordse M, van den Bersselaar DL, van de Kant KD, Muris JW, van Schayck OC, Dompeling E.

PLoS One. 2013 Oct 17;8(10):e77574. doi: 10.1371/journal.pone.0077574. eCollection 2013.

38.

Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model.

Ramos GF, van Asselt AD, Kuiper S, Severens JL, Maas T, Dompeling E, Knottnerus JA, van Schayck OC.

Eur J Health Econ. 2014 Nov;15(8):869-83. doi: 10.1007/s10198-013-0532-x. Epub 2013 Oct 6.

PMID:
24096902
39.

Pulmonary function after less invasive anterior instrumentation and fusion for idiopathic thoracic scoliosis.

Huitema GC, Jansen RC, Dompeling E, Willems P, Punt I, van Rhijn LW.

Scoliosis. 2013 Aug 21;8(1):14. doi: 10.1186/1748-7161-8-14.

40.

Multifactorial intervention for children with asthma and overweight (Mikado): study design of a randomised controlled trial.

Willeboordse M, van de Kant KD, de Laat MN, van Schayck OC, Mulkens S, Dompeling E.

BMC Public Health. 2013 May 21;13:494. doi: 10.1186/1471-2458-13-494.

41.

Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study.

Robroeks CM, van Berkel JJ, Jöbsis Q, van Schooten FJ, Dallinga JW, Wouters EF, Dompeling E.

Eur Respir J. 2013 Jul;42(1):98-106. doi: 10.1183/09031936.00010712. Epub 2013 May 3.

42.

[Palliative sedation in a man with oral cancer; the Royal Dutch Medical Association guidelines not always sufficient].

Smelt WL, Wulffraat ET, Broekhoff FJ, Dompeling EC, Vos-Westerman JH.

Ned Tijdschr Geneeskd. 2013;157(16):A5941. Dutch.

PMID:
23594874
43.

Exercise training in children with asthma: a systematic review.

Wanrooij VH, Willeboordse M, Dompeling E, van de Kant KD.

Br J Sports Med. 2014 Jul;48(13):1024-31. doi: 10.1136/bjsports-2012-091347. Epub 2013 Mar 23. Review.

PMID:
23525551
44.

A systematic review of CD14 and toll-like receptors in relation to asthma in Caucasian children.

Klaassen EM, Thönissen BE, van Eys G, Dompeling E, Jöbsis Q.

Allergy Asthma Clin Immunol. 2013 Mar 15;9(1):10. doi: 10.1186/1710-1492-9-10.

45.

A motivational interviewing intervention to PREvent PAssive Smoke Exposure (PREPASE) in children with a high risk of asthma: design of a randomised controlled trial.

Hutchinson SG, Mesters I, van Breukelen G, Muris JW, Feron FJ, Hammond SK, van Schayck CP, Dompeling E.

BMC Public Health. 2013 Feb 27;13:177. doi: 10.1186/1471-2458-13-177.

46.

To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis.

Vernooij-van Langen AM, Reijntjens S, van der Pal SM, Loeber JG, Dompeling E, Dankert-Roelse JE.

Eur J Med Genet. 2013 Apr;56(4):192-6. doi: 10.1016/j.ejmg.2013.01.006. Epub 2013 Jan 24.

PMID:
23352994
47.

Symptoms, but not a biomarker response to inhaled corticosteroids, predict asthma in preschool children with recurrent wheeze.

Klaassen EM, van de Kant KD, Jöbsis Q, Høvig ST, van Schayck CP, Rijkers GT, Dompeling E.

Mediators Inflamm. 2012;2012:162571. doi: 10.1155/2012/162571. Epub 2012 Dec 5.

48.

Exhaled breath profiling in diagnosing wheezy preschool children.

van de Kant KD, van Berkel JJ, Jöbsis Q, Lima Passos V, Klaassen EM, van der Sande L, van Schayck OC, de Jongste JC, van Schooten FJ, Derks E, Dompeling E, Dallinga JW.

Eur Respir J. 2013 Jan;41(1):183-8. doi: 10.1183/09031936.00122411.

49.

Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

van de Kant KD, van der Sande LJ, Jöbsis Q, van Schayck OC, Dompeling E.

Respir Res. 2012 Dec 21;13:117. doi: 10.1186/1465-9921-13-117. Review.

50.

Impact of bacterial colonization on exhaled inflammatory markers in wheezing preschool children.

van de Kant KD, Klaassen EM, van Aerde KJ, Damoiseaux J, Bruggeman CA, Stelma FF, Stobberingh EE, Muris JW, Jöbsis Q, van Schayck OC, Dompeling E.

J Breath Res. 2012 Dec;6(4):046001. doi: 10.1088/1752-7155/6/4/046001. Epub 2012 Sep 18. Erratum in: J Breath Res. 2012 Dec;6(4):049601.

PMID:
22990010

Supplemental Content

Loading ...
Support Center